Conferences - Results from #11560

AUA 2011 - 11C-choline PET/CT versus transrectal ultrasound-guided prostate biopsy to diagnose locally recurrent prostate cancer following radiation therapy - Session Highlights

WASHINGTON, DC USA (UroToday.com) - In this interesting presentation, Dr. Axel Heidenreich reported that PET/CT is superior to prostate biopsy in dectecting locally recurrent prostate cancer (CaP).

AUA 2011 - Activation of cannabinoid receptor 2 inhibits experimental cystitis - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Two experimental studies related to therapy caught my eye. Dale Bjorling and co-investigators from Madison, Wisconsin investigated whether activation of cannabinoid receptor 2 (CB2) alters severity of experimental cystitis induced by acrolein and referred hyperalgesia associated with cystitis.

AUA 2011 - Avoiding androgen deprivation therapy in men with high risk prostate cancer: The role of radical prostatectomy as initial treatment - Session Highlights

WASHINGTON, DC USA (UroToday.com) - The initial use of radical prostatectomy (RP) in patients with high-risk prostate cancer (CaP) avoids the need for androgen deprivation therapy (ADT) in many of these patients according to this presentation from the Cleveland Clinic.

AUA 2011 - Building a better cancer test: Updates on new biomarkers and genetic assays for bladder and prostate cancers - Press Release

WASHINGTON, DC USA (UroToday.com) - May 16, 2011 - Clinicians treating bladder and prostate cancers face significant challenges not only in treating, but also diagnosing these diseases.

AUA 2011 - Can an early PSA rule out subsequent advanced prostate cancer? Long term risk of advanced cancer in men with low PSA levels at age below 50 - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. Hans Lilja reported that a single PSA at age 45 is a strong predictor for the long-term risk of prostate cancer metastasis.

AUA 2011 - Capsaicin, a novel radiosensitizer, acts via a TRPV6 mediated mechanism - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Capsaicin is a compound found in the Capsicum species of plants and is a widely consumed food additive in areas with low prostate cancer incidence.

AUA 2011 - Characteristics and treatment outcomes of 458 patients with interstitial cystitis in Japan - Session Highlights

WASHINGTON, DC USA (UroToday.com) - In a Japanese review of 458 patients with IC/BPS at 38 hospitals of 11 universities treated from 2002-2006, Hideki Enokida and colleagues from Kagoshima reported that hydrodistention was the most effective treatment for these patients.

AUA 2011 - Current treatment patterns and characteristics of castration resistant prostate cancer (CRPC) patients; a European survey - Session Highlights

WASHINGTON, DC USA (UroToday.com) - A significant number of European physicians who manage advanced prostate cancer (CaP) do not continue the use of a luteinizing hormone releasing hormone agonist (LHRHa) when giving chemotherapy, according to this presentation.

AUA 2011 - Cyclosporine A for refractory interstitial cystitis: Experience of two tertiary centers - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Monica Cardona and colleagues from Lexington, Kentucky and Tulsa, Oklahoma reviewed their experience with oral cyclosporine A for refractory IC/BPS.

AUA 2011 - Demographics and clinical characteristics of the RICE IC/BPS cohort - Session Highlights

WASHINGTON, DC USA (UroToday.com) - The latest data from the Rand Interstitial Cystitis Epidemiology (RICE) survey compared the RICE community cohort with a smaller, more traditional IC/BPS clinical cohort.

AUA 2011 - Evaluation of pentosan polysulfate sodium in the treatment of feline interstitial cystitis: A randomized, placebo-controlled clinical trial - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. Larry Adams and colleagues evaluated the efficacy of pentosan polysulphate for improving lower urinary tract signs in 107 cats with feline interstitial cystitis in a 6 month multicenter, double-blind, randomized, placebo-controlled clinical trial.

AUA 2011 - Evaluation of the prostate health index (PHI) in the 2 to 4, and 4 to 10 ng/ml PSA ranges: Results from a multi-site, prospective, clinical evaluation - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. William Catalona reported that the operating characteristics of the prostate health index (phi) shows improved discrimination of cancer from benign disease compared to PSA and %free PSA.

AUA 2011 - Heritability of interstitial cystitis/painful bladder syndrome symptoms in women: A twin study - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Niloofar Afari and colleagues from Seattle, Washington looked at the nature vs. nurture question in IC/BPS.

AUA 2011 - Hospital discharges indicate more men may require surgery for BPH - Press Release

WASHINGTON, DC USA (UroToday.com) - May 17, 2011 -

Rising numbers of acute renal failure cases in BPH patients suggests more need full workup, possible intervention

AUA 2011 - How soon can we identify men at high risk for prostate cancer death? An early surveillance strategy for prostate cancer - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. Andrew Vickers reported that long-term risk of prostate cancer (CaP) death can be predicted on the basis of a single blood test before the age of 50, and actively targeting this population may avoid up to half of CaP deaths.

AUA 2011 - HPV, virus that causes cervical cancer, found prevalent in males in study that suggests vaccinations for boys as well as girls - Press Release

WASHINGTON, DC USA (UroToday.com) - May 17, 2011 -

High-risk human papillomavirus (HPV) found in 10 percent of men and boys in study

AUA 2011 - Medical factors are poor predictors of perception of pain and urgency in interstitial cystitis (IC) - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Two groups focused on predictors of pain and urgency in IC/BPS.

AUA 2011 - Men with isolated high grade prostatic intraepithelial neoplasia (HGPIN) have a high risk of prostate cancer in long-term follow-up: Results from a prospective multicenter, randomized, placebo-controlled prostate cancer prevention trial - Sessi

WASHINGTON, DC USA (UroToday.com) - Men with isolated HGPIN are at high risk for the development of prostate cancer and should be aggressively monitored with follow-up PSA and prostate needle biopsy, according to work by Dr. Samir Taneja and colleagues.

AUA 2011 - New data provide insight into pediatric urology conditions, treatment - Press Release

WASHINGTON, DC USA (UroToday.com) - May 16, 2011

Research brings new approaches to pediatric nephrolithiasis, enuresis and ureteropelvic junction obstruction management

AUA 2011 - O’leary-Sant questionnaire changes after intravesical instillation of nociceptin/orphanin FQ (n/ofq) in patients with interstitial cystitis/painful bladder syndrome (IC/PBS). A pilot study - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Maria Celso and colleagues from Florence, Italy investigated the efficacy of intravesical instillation of the naturally occurring peptide nociceptin/orphanin FQ.

Page 579 of 588

Login